-The Times of India NEW DELHI: Former chief election commissioner N Gopalaswamy and ex-Admirals R H Tahiliani and L Ramdas along with six other eminent persons on Monday petitioned the Supreme Court challenging appointment of former defence secretary Sashi Kant Sharma as the Comptroller and Auditor General (CAG). This is the second PIL within a fortnight, and follows one filed by advocate M L Sharma, who, too, had challenged the discretion vested...
More »SEARCH RESULT
Total Matching Records found : 2506
It’s official: Indian economy slowed to a 10-year low of 5% in 2012-13
-The Times of India The Indian economy grew at its slowest pace in a decade in 2012-13, posing another fresh challenge for the UPA coalition to revive growth and boost sentiment ahead of the general elections next year. Data released by the Central Statistical Organization (CSO) on Friday showed that the economy grew 5% in 2012-13, compared to 6.2% expansion in the previous year. It was in line with the advanced...
More »The right medicine
-The Business Standard Govt should streamline its free medicines plan The Centre is reportedly going to shelve a plan to procure generic drugs for free supply to patients throughout the country. This is a serious error. Reportedly, states will instead be asked to do so; but, if a perceived inability to procure, stock and distribute these drugs is the reason for backtracking on the plan, how precisely will states be free of...
More »Aruna Roy, social activist and NCPRI member interviewed by Pallavi Polanki
-Firstpost.com After the UPA-II released its self-congratulatory 79-page ‘Report card to the People', National Advisory Council (NAC) member and leading social activist Aruna Roy has come down heavily on the government for its poor performance in the social sector. Roy, an instrumental force behind the Right to Information Act, criticised the government for stalling on essential legislations such as the Food Security Bill, the Land Acquisition Bill and the Lokpal Bill. Roy spoke...
More »A deception most foul-Narayan Lakshman
-The Hindu Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...
More »
